DECEMBER - 20206December - 14 - 2020, volume 04 - Issue 27 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerJohn GothamSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comThe race for next-gen series of painless and reliable glucose monitoring devices is on. As technology advances, both diagnostic techniques, as well as equipment, improve. Great effort has been dedicated to the development of non-invasive glucose monitoring devices, which may significantly improve the quality of life for people suffering from diabetes and facilitate their compliance with glucose monitoring. Since incorporating user requirements into device development may potentially increase user acceptance and improve patient safety and device effectiveness, special attention is given to usability, user experience, and applicability for home use. Likewise, a favourable non-invasive glucose monitoring device must overcome the combination of accuracy, usability and applicability challenges. Improving the assessment of device usability and acceptance may shed light on primary user concerns and may thus offer a meaningful step forward in the commercialization of non-invasive glucose monitoring devices. While advances have been made, the reliability and the calibration of non-invasive instruments could still be improved, and more studies carried out under different physiological conditions of metabolism, bodily fluid circulation, and blood components are needed.Thus, partnering with a leading-edge MedTech enterprise could be of great help to companies who are looking to ramp up their product offerings and handle multiple distribution channels simultaneously while entering new markets. In this edition of MedTech Outlook, we bring you the story of the top non-invasive device solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best devices according to your requirements.Let us know your thoughts!The Game-Changers in Non-Invasive Medical TechnologiesSarah FernandesEDITORIAL
< Page 5 | Page 7 >